Headlines

Boston Scientific (BSX) announces agreement to acquire Penumbra (PEN) for USD 374/shr and deal values PEN at USD 14.5bln

Newsquawk Staff ·

Boston Scientific (BSX) announces agreement to acquire Penumbra (PEN) for USD 374/shr and deal values PEN at USD 14.5bln.

What it means

Boston Scientific's acquisition of Penumbra for $14.5 billion at $374 per share indicates a strategic move to enhance its portfolio in the healthcare equipment sector. This deal may prompt a reevaluation of valuations within the healthcare space and could impact investor sentiment towards both firms, as well as raise questions regarding potential regulatory scrutiny in future mergers.

Related headlines